Purdue's Patents for Oxycontin Invalidated

Law360, New York (January 5, 2004, 12:00 AM EST) -- A U.S. District Court judge in Manhattan invalidated Purdue Pharma’s patents protecting the controversial and widely abused pain killer Oxycontin, clearing the way for drug maker Endo Pharmaceuticals to sell a generic version.

U.S. District Judge Sidney H. Stein ruled that while Endo infringed three of Purdue's patents on the drug, Endo "has proven by clear and convincing evidence that the patents are invalid due to Purdue's inequitable conduct before the Patent and Trademark Office during the prosecution of the patents in suit."

Purdue had sued...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.